EFFECTS OF QUERCETIN AND DIHYDROQUERCETIN FLAVONOIDS ON CARDIAC MITOCHONDRIAL DYSFUNCTION
Keywords:
cardiac mitochondria, cardiac tissue, dihydroquercetin, flavonoids, liquid chromatography–mass spectrometry, mitochondrial dysfunction, oxidative injury, quercetin.Abstract
Reduced cardiac mitochondrial respiration, disrupted membrane potential, and oxidative injury form an interconnected system, yet the effects of quercetin and dihydroquercetin on these processes remain inconsistently interpreted. The study aimed to compare the mechanistic influence of both flavonoids on the functional state, oxidative status, and membrane-related characteristics of isolated cardiac mitochondria. An experimental animal study used a factorial design, while liquid chromatography–mass spectrometry and high-performance liquid chromatography were applied to characterize the flavonoid composition. Mitochondrial respiratory activity, membrane potential, and oxidative-injury endpoints were assessed with standardized laboratory protocols. Between-group comparisons were performed using one-way and two-way analysis of variance followed by post-hoc testing. The resulting profile showed that quercetin and dihydroquercetin produced distinct changes in oxidative processes within cardiac mitochondria, but neither compound fully restored mitochondrial function under the examined conditions. Joint evaluation of respiration, membrane potential, and oxidative endpoints demonstrated that a single biomarker cannot adequately represent the mitochondrial response to flavonoid exposure. The scientific contribution lies in defining a multidimensional framework for comparing two flavonoids through coordinated chemical identification, functional measurement, and multifactor statistical analysis. This framework links compound identity with organelle-level responses without reducing mitochondrial dysfunction to one oxidative indicator. Future work should examine concentration–response relationships, chronic safety, and ischemia–reperfusion injury in intact myocardium. The findings establish a mechanistic basis for evaluating flavonoid-specific mitochondrial effects before therapeutic extrapolation.References
— 2009. — Vol. 417. — № 1. — P. 1–13. — DOI: 10.1042/BJ20081386.
2. Boots A.W., Haenen G.R.M.M., Bast A. Health effects of quercetin: From antioxidant to nutraceutical // European Journal of Pharmacology. — 2008. — Vol. 585. — № 2–3. — P. 325–337. — DOI: 10.1016/j.ejphar.2008.03.008.
3. Formica J.V., Regelson W. Review of the biology of quercetin and related bioflavonoids // Food and Chemical Toxicology. — 1995. — Vol. 33. — № 12. — P. 1061–1080. — DOI: 10.1016/0278-6915(95)00077-1.
4. Ganesan K., Xu B. Molecular targets of quercetin and its derivatives in cancer therapy // Nutrition and Cancer. — 2017. — Vol. 69. — № 5. — P. 687–700. — DOI: 10.1080/01635581.2017.1316871.
5. Boots A.W., Drent M., de Boer V.C.J. et al. Quercetin reduces markers of oxidative stress and inflammation in humans // British Journal of Nutrition. — 2011. — Vol. 105. — № 5. — P. 686–694. — DOI: 10.1017/S0007114510005277.
6. Li Y., Yao J., Han C. et al. Quercetin, inflammation and immunity // Nutrients. — 2016. — Vol. 8. — № 3. — Article 167. — DOI: 10.3390/nu8030167.
7. D’Andrea G. Quercetin: A flavonol with multifaceted therapeutic applications? // Fitoterapia. — 2015. — Vol. 106. — P. 256–271. — DOI: 10.1016/j.fitote.2015.09.018.
8. Brand M.D. The sites and topology of mitochondrial superoxide production // Experimental Gerontology. — 2010. — Vol. 45. — № 7–8. — P. 466–472. — DOI: 10.1016/j.exger.2010.01.003.
9. Zorov D.B., Juhaszova M., Sollott S.J. Mitochondrial reactive oxygen species and redox signaling // Circulation Research. — 2014. — Vol. 114. — № 9. — P. 1531–1546. — DOI: 10.1161/CIRCRESAHA.114.303570.
10. Bernardi P., Di Lisa F. The mitochondrial permeability transition pore: Molecular nature and role as a target in cardioprotection // Journal of Molecular and Cellular Cardiology. — 2015. — Vol. 78. — P. 100–106. — DOI: 10.1016/j.yjmcc.2014.10.005.
11. Heusch G. Molecular basis of cardioprotection: Signal transduction in ischemic pre-, post-, and remote conditioning // Circulation Research. — 2015. — Vol. 116. — № 4. — P. 674–699. — DOI: 10.1161/CIRCRESAHA.116.305348.
12. Powers S.K., Murlasits Z., Wu M., Kavazis A.N. Ischemia-reperfusion-induced cardiac injury: A brief review // Medicine and Science in Sports and Exercise. — 2007. — Vol. 39. — № 9. — P. 1529–1536. — DOI: 10.1249/mss.0b013e3180d099d4.
13. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. — Oxford: Oxford University Press, 2015. — 944 p.
14. Russo M., Spagnuolo C., Tedesco I., Russo G.L. The flavonoid quercetin in disease prevention and therapy: Facts and fancies // Biochemical Pharmacology. — 2012. — Vol. 83. — № 1. — P. 6–15. — DOI: 10.1016/j.bcp.2011.08.010.
15. Dajas F. Life or death: Neuroprotective and anticancer effects of quercetin // Journal of Ethnopharmacology. — 2012. — Vol. 143. — № 2. — P. 383–396. — DOI: 10.1016/j.jep.2012.07.005.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.










